neurology conferences
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age...
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Spring 2013 Neuroscience Symposium
The Spring Neuroscience Symposium is a comprehensive educational overview developed for healthcare providers involved in the care of patients with cerebrovascular,...
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
12th Annual Pediatric Neuroscience Update
This course is designed for practitioners who are respon- sible for treating children with neurological, neurodevel- opmental, and neurobehavioral disorders....
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Neurology/Psychiatry for Primary Care
Upon completion of this program, participants should be better able to: - Review a neurological exam - Explain the differential diagnosis of seizures and...
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Optimizing the Risk-Benefit Therapeutic Equation for...
Neurologic specialists and their patients understand that multiple sclerosis (MS) is a lifelong, immune-mediated progressive disorder. The early age of onset...
Minimizing Risks and Maximizing Efficacy for Management...
Multiple sclerosis (MS) affects nearly 400,000 people in the United States and over 2.5 million people worldwide. Diagnostic methods and treatment plans developed...
Users
Channels
-
UCD Medicine
medical institution
-
High Impact - Medical Animation
medical institution
-
Alila Medical Media
medical institution
-
Amerra - Advanced Medical Visualizations
medical institution
-
Neurologic Exam Videos
medical institution